Next Article in Journal
SAR Modeling to Predict Ames Mutagenicity Across Different Salmonella typhimurium Strains
Previous Article in Journal / Special Issue
Network Pharmacology Analysis and Experimental Study of Yinchen Against Neuroinflammation in Ischemic Stroke
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Therapeutic Potential of Gynostemma pentaphyllum (Thunb.) Makino Against COVID-19 Identified Through Network Pharmacology

1
Pharmacomicrobiomics Research Center, College of Pharmacy, Hanyang University, Ansan 15588, Republic of Korea
2
New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea
3
College of Pharmacy, Jeju National University, Jeju 63243, Republic of Korea
4
GENECT, Konkuk University Campus Town, Seoul 05073, Republic of Korea
5
Key Laboratory of Ethnomedicine, Ministry of Education, Minzu University of China, Beijing 100081, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceuticals 2025, 18(12), 1851; https://doi.org/10.3390/ph18121851 (registering DOI)
Submission received: 19 September 2025 / Revised: 26 November 2025 / Accepted: 1 December 2025 / Published: 4 December 2025
(This article belongs to the Special Issue Network Pharmacology of Natural Products, 2nd Edition)

Abstract

Background/Objectives: The ongoing challenges posed by COVID-19 have highlighted the need for multi-target therapeutic strategies addressing both acute immune responses and systemic complications. Gynostemma pentaphyllum (Thunb.) Makino, a traditional herbal medicine rich in flavonoids and saponins, exhibits diverse pharmacological activities, including immunomodulatory and cardiovascular effects. In this study, we investigated the potential of G. pentaphyllum as a complementary treatment for COVID-19 using a network pharmacology approach combined with molecular docking analysis. Methods: To delve into the therapeutic mechanisms of G. pentaphyllum, we identified 59 active compounds and predicted 408 protein targets, of which 19 overlapped with COVID-19-associated genes, including IL1B, IL6, TNF, ACE, and REN. GO and KEGG enrichment analyses were conducted to determine relevant biological processes and pathways, focusing on cytokine signaling, inflammatory responses, and the renin–angiotensin system. Network analyses evaluated interactions of flavonoids and triterpenoid saponins with immunological, inflammatory, renin–angiotensin system, and host entry pathways. Molecular docking was performed to validate the binding affinities of key compounds to their predicted targets. Results: The compound–target–pathway network revealed class-specific patterns: flavonoids primarily mapped to immuno-inflammatory nodes, whereas triterpenoid saponins were enriched for renin–angiotensin system/host-entry–related targets. Docking energies spanned −6.1 to −11.9 kcal/mol, with six compound–target pairs ≤ −10.0 kcal/mol. Notably, NOS2–rutin (−11.9 kcal/mol), NOS2–gypenoside LI (−11.6 kcal/mol), and ACE–gypenoside LI (−11.3 kcal/mol) showed the strongest affinities. Conclusions: These findings provide evidence that G. pentaphyllum exerts therapeutic effects through the complementary actions of flavonoid and saponin components, each modulating distinct molecular pathways. This dual mechanistic potential underscores the value of G. pentaphyllum as a versatile therapeutic for COVID-19 therapy.
Keywords: Gynostemma pentaphyllum; flavonoids; triterpenoid saponins; network pharmacology; molecular docking; COVID-19 Gynostemma pentaphyllum; flavonoids; triterpenoid saponins; network pharmacology; molecular docking; COVID-19
Graphical Abstract

Share and Cite

MDPI and ACS Style

Kim, M.H.; Won, J.A.; Yu, J.S.; Kim, S.M.; Lee, D.K.; Piao, X.-L.; Yoo, H.H. Therapeutic Potential of Gynostemma pentaphyllum (Thunb.) Makino Against COVID-19 Identified Through Network Pharmacology. Pharmaceuticals 2025, 18, 1851. https://doi.org/10.3390/ph18121851

AMA Style

Kim MH, Won JA, Yu JS, Kim SM, Lee DK, Piao X-L, Yoo HH. Therapeutic Potential of Gynostemma pentaphyllum (Thunb.) Makino Against COVID-19 Identified Through Network Pharmacology. Pharmaceuticals. 2025; 18(12):1851. https://doi.org/10.3390/ph18121851

Chicago/Turabian Style

Kim, Min Ho, Jin Ah Won, Jun Sang Yu, Su Min Kim, Dong Keun Lee, Xiang-Lan Piao, and Hye Hyun Yoo. 2025. "Therapeutic Potential of Gynostemma pentaphyllum (Thunb.) Makino Against COVID-19 Identified Through Network Pharmacology" Pharmaceuticals 18, no. 12: 1851. https://doi.org/10.3390/ph18121851

APA Style

Kim, M. H., Won, J. A., Yu, J. S., Kim, S. M., Lee, D. K., Piao, X.-L., & Yoo, H. H. (2025). Therapeutic Potential of Gynostemma pentaphyllum (Thunb.) Makino Against COVID-19 Identified Through Network Pharmacology. Pharmaceuticals, 18(12), 1851. https://doi.org/10.3390/ph18121851

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop